Facebook might turn out to be another IPO that was a disappointment for retail investors--but a smash hit for the secondary markets that absorbed its trajectory.
2 min read · 21 May 2012
Today's Facebook's big day--but the company faces a slew of challenges, coming in the form of a crowded social space, a hazy mobile horizon and regulatory uncertainty.
3 min read · 18 May 2012
Today's First Read has questions: Where are Americans on gay marriage? What is Quora worth? And what can US taxpayers afford to support?
1 min read · 16 May 2012
Underlying Facebook's latest deal spree is the company transitioning its revenue expectations to mobile users.
2 min read · 15 May 2012
Today's First Read--including the beginning (I hope) of the STOP Stop & Frisk campaign, Mitt's early years, and the grocery bag of death.
1 min read · 11 May 2012
The VC with a string of smash-hit investments is about to close its biggest fund ever.
2 min read · 09 May 2012
If you don't eat your life sciences portfolio, you can't have any Sequoia for dessert! As LPs continue to digest medical technology VC investments, GPs are left hungry for more capital.
2 min read · 09 May 2012
VCs are having a tougher time getting capital to put to work for life sciences and medical technology entrepreneurs. Is the answer to just hope to lock in funding on campus?
3 min read · 09 May 2012
This morning's First Read comes with some bad news for one entrepreneur, some good news for the folks at Paperless Post, and a dividend recap to boot.
1 min read · 08 May 2012
Private equity hasn't fallen out of favor with mid-market executives, who are increasingly likely to partner up with PE for M&A.
2 min read · 07 May 2012
